Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Molecule Helps Breast Cancer Cells To Survive In The Bone Marrow
Patients who survive an initial diagnosis of breast cancer often succumb to the disease years later when the cancer shows up in a different part of the body. Now, scientists have identified key signals that support the long term survival of breast cancer cells after they have spread to the bone marrow. The research, published by Cell Press in the July issue of the journal Cancer Cell, may lead to development of treatment strategies that decrease the likelihood of breast cancer recurrence in the bone and other organs.
generic viagra online
SNM's Clinical Trials Network Expands European Membership Of PET Biomarker Manufacturers
SNM"s Clinical Trials Network have announced that several leading commercial providers of PET radiopharmaceuticals in Europe have registered their manufacturing sites with the network. SNM"s Clinical Trials Network is an initiative designed to address the need for streamlined drug discovery through the integration of imaging biomarkers into multi-center clinical trials.
News of the day
Long-Suffering Rohingya In Bangladesh Face Unacceptable Abuse
Thousands of unregistered Rohingya refugees living in the Kutupalong makeshift camp, Bangladesh, are being forcibly displaced from their homes, in an act of intimidation and abuse by the local authorities. The international medical organization Doctors Without Border/Mç©decins Sans Frontiç¨res (MSF) has treated numerous people for injuries, of which the majority were women and children. Furthermore, MSF has witnessed countless destroyed homes and heard many reports of people being warned to remove their own shelters or face the consequences.
Endocrinology

ASGS Issues Position Statement Supporting TIF Natural Orifice Surgery For GERD

EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), announced that the American Society of General Surgeons (ASGS) has published a position statement endorsing its Transoral Incisionless Fundoplication (TIF) procedure for the treatment of GERD. ASGS is the preeminent society of general surgeons with membership exceeding 2,000. In the position statement published on the society"s website , ASGS" Board of Trustees states, "transoral incisionless fundoplication (TIF) stands in sharp contrast to other natural orifice options in that it adheres to the fundamental surgical principle, which has guided surgical care for GERD for more than 50 years; specifically the creation of a full thickness gastric fundoplication in support of the lower esophageal sphincter." Based in part on the results of recently published scientific information on the long-term efficacy and durability of the TIF fundoplication procedure (Cadiere et al, Surgical Endoscopy, March 2009), the statement continues, "In clinical studies the TIF procedure has been shown to offer comparable results to more traditional procedures in the treatment of selected patients with GERD." "Surgical care is a continuously evolving healing art, and the pursuit of excellence demands that we continuously evaluate new innovations," explained Robert Sewell, MD, immediate past president of ASGS . "ASGS is excited by the prospect of natural orifice surgery"s ability to further revolutionize the way we treat our patients. One example of such an innovation is the new TIF antireflux procedure, which appears to offer results that are comparable to more invasive techniques. Tens of millions of patients in the U.S. suffer with a variety of symptoms associated with GERD, and many of them would be better served by surgical treatment. Any such treatment must be both effective and able to be performed with the lowest possible risk." "This position statement is an important development in the adoption of natural orifice surgery and TIF specifically," commented Thierry Thaure, President and Chief Executive Officer of EndoGastric Solutions. "TIF is gaining acceptance among ASGS members and non-member general surgeons throughout the U.S. and is on the cusp of broad adoption. ASGS" endorsement will support EGS" ongoing efforts in surgeon training, reimbursement and patient awareness as we invest in making TIF the standard of care in GERD treatment." EndoGastric Solutions®


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009